drugset / Trial / NCT00281593
Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
Treatment
Summary
To identify dose combinations of telmisartan and ramipril that are more effective in reducing diastolic blood pressure than each of the respective monotherapies in patients with Stage I or II hypertension.
Timeline
- Start
- 2006-04
- Primary completion
- 2007-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramipril | Small molecule | 1.25 mg | — |
| Subject | Ramipril | Small molecule | 10 mg | — |
| Subject | Ramipril | Small molecule | 20 mg | — |
| Subject | Telmisartan | Other / unclassified | 20 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |